Vivani Medical, Inc.
VANINASDAQHealthcare● Active
$1.15
$-0.03(-2.54%)
Market Cap$67939999
P/E Ratio—
52W High$1.92
52W Low$0.923
Vivani Medical, Inc. (VANI) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
VANI · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
-$0.08
Est. -$0.08 · +0.0%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
✓ 3-Quarter EPS Beat Streak
VANI reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 12, 2026 | -$0.08 | — | — | — | — | — |
| — Q2 FY2026 | May 13, 2026 | -$0.08 | -$0.08 | +0.0% | — | — | — |
| — Q1 FY2026 | Mar 26, 2026 | -$0.09 | -$0.09 | +0.0% | — | — | — |
| ▲ Q4 FY2025 | Nov 13, 2025 | -$0.12 | -$0.11 | +8.3% | — | — | — |
| ▼ Q3 FY2025 | Aug 13, 2025 | -$0.10 | -$0.12 | -20.0% | — | — | — |
| ▼ Q2 FY2025 | May 13, 2025 | -$0.10 | -$0.11 | -10.0% | — | — | — |
| ▼ Q1 FY2025 | Mar 31, 2025 | -$0.10 | -$0.11 | -10.0% | $0.00B | — | — |
| — Q4 FY2024 | Nov 13, 2024 | -$0.11 | -$0.11 | +0.0% | — | — | — |
Q3 FY2026
Aug 12, 2026
EPS Actual
—
EPS Est.
-$0.08
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 13, 2026
EPS Actual
-$0.08
EPS Est.
-$0.08
EPS Surpr.
+0.0%
Revenue
—
Q1 FY2026
Mar 26, 2026
EPS Actual
-$0.09
EPS Est.
-$0.09
EPS Surpr.
+0.0%
Revenue
—
Q4 FY2025
Nov 13, 2025Beat
EPS Actual
-$0.11
EPS Est.
-$0.12
EPS Surpr.
+8.3%
Revenue
—
Q3 FY2025
Aug 13, 2025Miss
EPS Actual
-$0.12
EPS Est.
-$0.10
EPS Surpr.
-20.0%
Revenue
—
Q2 FY2025
May 13, 2025Miss
EPS Actual
-$0.11
EPS Est.
-$0.10
EPS Surpr.
-10.0%
Revenue
—
Q1 FY2025
Mar 31, 2025Miss
EPS Actual
-$0.11
EPS Est.
-$0.10
EPS Surpr.
-10.0%
Revenue
$0.00B
Q4 FY2024
Nov 13, 2024
EPS Actual
-$0.11
EPS Est.
-$0.11
EPS Surpr.
+0.0%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-0.09 | $-0.09 | $-0.09 | 1 |
| Q3 FY2026 | $-0.08 | $-0.08 | $-0.08 | 1 |
| Q2 FY2026 | $-0.09 | $-0.09 | $-0.09 | 1 |
| Q1 FY2026 | $-0.08 | $-0.08 | $-0.08 | 1 |
| Q4 FY2025 | $-0.09 | $-0.09 | $-0.09 | 1 |
| Q3 FY2025 | $-0.11 | $-0.11 | $-0.11 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 13, 2026 | +0.0% | $1.14 | $1.16 | +1.75% |
| ▲ Q1 FY2026 | Mar 26, 2026 | +0.0% | $1.13 | $1.08 | -4.42% |
| ▲ Q4 FY2025 | Nov 13, 2025 | +8.3% | $1.53 | $1.36 | -11.11% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -20.0% | $1.27 | $1.26 | -0.79% |
| ▼ Q2 FY2025 | May 13, 2025 | -10.0% | $1.03 | $1.05 | +1.94% |
| ▼ Q1 FY2025 | Mar 31, 2025 | -10.0% | $1.11 | $1.05 | -5.41% |
| ▲ Q4 FY2024 | Nov 13, 2024 | +0.0% | $1.25 | $1.39 | +11.20% |
| ▲ Q3 FY2024 | Aug 13, 2024 | +16.7% | $1.16 | $1.16 | +0.00% |
Q2 FY2026+1.75%
Report Date
May 13, 2026
EPS Beat/Miss
+0.0%
Price Before
$1.14
Price After
$1.16
Q1 FY2026-4.42%
Report Date
Mar 26, 2026
EPS Beat/Miss
+0.0%
Price Before
$1.13
Price After
$1.08
Q4 FY2025-11.11%
Report Date
Nov 13, 2025
EPS Beat/Miss
+8.3%
Price Before
$1.53
Price After
$1.36
Q3 FY2025-0.79%
Report Date
Aug 13, 2025
EPS Beat/Miss
-20.0%
Price Before
$1.27
Price After
$1.26
Q2 FY2025+1.94%
Report Date
May 13, 2025
EPS Beat/Miss
-10.0%
Price Before
$1.03
Price After
$1.05
Q1 FY2025-5.41%
Report Date
Mar 31, 2025
EPS Beat/Miss
-10.0%
Price Before
$1.11
Price After
$1.05
Q4 FY2024+11.20%
Report Date
Nov 13, 2024
EPS Beat/Miss
+0.0%
Price Before
$1.25
Price After
$1.39
Q3 FY2024+0.00%
Report Date
Aug 13, 2024
EPS Beat/Miss
+16.7%
Price Before
$1.16
Price After
$1.16
Avg Beat Reaction-0.52%
Avg Miss Reaction-1.42%
Beat Rate5 / 8 quarters
Largest Move+11.20% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: VANI ends December
Vivani Medical, Inc. (VANI) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $-0.08 (in line with the analyst consensus of $-0.08). VANI has beaten EPS estimates for 3 consecutive quarters. The next VANI earnings date is expected around September 1, 2026.
Each quarter, investors track VANI earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. VANI revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
VANI's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
VANI earnings · 4 questionsVivani Medical, Inc.'s next earnings report is expected around September 1, 2026. VANI typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; VANI historically reports after market close (AMC).
VANI earnings datewhen is VANI earningsVANI next earnings datewhen does VANI report earningsVANI earnings calendar
▸ Source: FMP · Vivani Medical, Inc. SEC filings · US GAAP · Vivani Medical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026